Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 1,623,478 |
|
|||||
| News | - | ||||||
| Day High | 0.48 | Low High |
|||||
| Day Low | 0.4573 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0159 | -3.31% | 0.4641 | 18:17:50 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.4752 | 0.4573 | 0.48 | 0.4728 | 0.48 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,739 | 1,623,478 | US$ 0.4745002 | US$ 770,341 | - | 0.2002 - 2.03 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:11:15 | formt | 554 | US$ 0.4641 | USD |
Outlook Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 122.32M | 260.25M | - | 0 | -66.05M | -0.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Outlook Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.4505 | 0.4982 | 0.4488 | 0.4753527 | 1,711,892 | 0.0136 | 3.02% |
| 1 Month | 0.34 | 0.5346 | 0.3394 | 0.452958 | 3,652,154 | 0.1241 | 36.5% |
| 3 Months | 0.2154 | 0.90 | 0.2002 | 0.4550181 | 8,295,103 | 0.2487 | 115.46% |
| 6 Months | 1.51 | 2.03 | 0.2002 | 0.5400025 | 6,515,671 | -1.05 | -69.26% |
| 1 Year | 1.04 | 2.03 | 0.2002 | 0.5941612 | 3,596,740 | -0.5759 | -55.38% |
| 3 Years | 1.22 | 4.26 | 0.2002 | 1.28 | 2,332,319 | -0.7559 | -61.96% |
| 5 Years | 5.60 | 20.00 | 0.2002 | 1.44 | 2,034,601 | -5.14 | -91.71% |
Outlook Therapeutics Description
| Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |
